A03789Introduced in the Assembly
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Introduced by David Weprin, District 24
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Where it stands
reported referred to rules
May 20, 2026
How did lawmakers vote?
AssemblyStage: Assembly Insurance Committee: Favorable refer to committee Rules · May 20, 2026
20
Yes
2
No
3
Absent or Not Voting
25 assemblymembers recorded in this Assembly vote. Colors show vote categories only, not whether a vote was good or bad.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
See how each assemblymember voted
| Assemblymember | District | Vote |
|---|---|---|
| Jarett Gandolfo | 7 | No |
| Charles Lavine | 13 | Yes |
| Jacob Blumencranz | 15 | Yes |
| David Weprin | 24 | Yes |
| Sam Berger | 27 | Yes |
| Khaleel Anderson | 31 | Yes |
| Vivian Cook | 32 | Absent |
| Catalina Cruz | 39 | Yes |
| Kalman Yeger | 41 | Yes |
| Simcha Eichenstein | 48 | Yes |
Bill history
referred to insurance
reported referred to rules
amend and recommit to rules 3789a
referred to insurance
amend by restoring to original print 3789
reported referred to rules
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.